Cabot (NYSE:CBT) Sets New 12-Month Low Following Analyst Downgrade

Cabot Corporation (NYSE:CBT) shares hit a new 52-week low on Thursday after UBS Group lowered their price target on the stock from $82.00 to $65.00. UBS Group currently has a neutral rating on the stock. Cabot traded as low as $59.60 and last traded at $60.46, with a volume of 929875 shares changing hands. The stock had previously closed at $61.24.

A number of other research analysts have also commented on the stock. Mizuho dropped their price objective on shares of Cabot from $90.00 to $88.00 and set an “outperform” rating on the stock in a research note on Friday, October 3rd. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a report on Wednesday, October 8th. One research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $79.33.

Insider Buying and Selling at Cabot

In other news, CEO Sean D. Keohane sold 114,436 shares of the stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $79.28, for a total value of $9,072,486.08. Following the completion of the transaction, the chief executive officer owned 361,518 shares in the company, valued at $28,661,147.04. This trade represents a 24.04% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 3.03% of the stock is currently owned by company insiders.

Institutional Trading of Cabot

A number of institutional investors have recently added to or reduced their stakes in the stock. American Century Companies Inc. increased its holdings in Cabot by 11.1% in the second quarter. American Century Companies Inc. now owns 1,664,728 shares of the specialty chemicals company’s stock valued at $124,855,000 after buying an additional 166,460 shares in the last quarter. Bank of America Corp DE grew its holdings in shares of Cabot by 2.0% in the 2nd quarter. Bank of America Corp DE now owns 1,620,440 shares of the specialty chemicals company’s stock worth $121,533,000 after acquiring an additional 31,947 shares during the period. Dimensional Fund Advisors LP increased its stake in Cabot by 8.2% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,426,693 shares of the specialty chemicals company’s stock valued at $118,606,000 after purchasing an additional 108,397 shares in the last quarter. Geode Capital Management LLC raised its holdings in Cabot by 1.8% during the second quarter. Geode Capital Management LLC now owns 1,421,934 shares of the specialty chemicals company’s stock worth $106,656,000 after purchasing an additional 25,717 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. boosted its position in Cabot by 1.7% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 1,190,886 shares of the specialty chemicals company’s stock worth $99,010,000 after purchasing an additional 19,333 shares in the last quarter. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot Price Performance

The company has a market cap of $3.27 billion, a price-to-earnings ratio of 8.03 and a beta of 0.90. The company has a fifty day simple moving average of $73.44 and a two-hundred day simple moving average of $75.55. The company has a quick ratio of 1.41, a current ratio of 2.13 and a debt-to-equity ratio of 0.66.

Cabot (NYSE:CBT) last released its quarterly earnings data on Monday, November 3rd. The specialty chemicals company reported $1.70 EPS for the quarter, missing the consensus estimate of $1.72 by ($0.02). Cabot had a return on equity of 25.68% and a net margin of 11.14%.The business had revenue of $899.00 million during the quarter, compared to analysts’ expectations of $967.02 million. During the same quarter in the prior year, the firm earned $1.80 earnings per share. Cabot’s quarterly revenue was down 10.2% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. On average, equities research analysts anticipate that Cabot Corporation will post 7.57 earnings per share for the current fiscal year.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.